Medicine
Goprelto 40 mg/mL nasal solution
Goprelto 40 mg/mL nasal solution is a prescription medicine containing Cocaine for nasal use, marketed by Lxo, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Avoid freezing. Store upright at 20° to 25°C (68° to 77°F), excursions…
Key facts
- Active ingredient (INN)
- Cocaine
- Brand
- Goprelto
- Strength
- 40 mg/mL
- Dosage form
- Nasal solution
- Route
- Nasal
- Packs
- 1 bottle
- Marketing authorisation holder
- Lxo
- Manufacturer
- Lxo
- Origin register
- US FDA, United States
- Storage
- Avoid freezing. Store upright at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59° to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Schedule CII
- ATC code
- N01BC01 Cocaine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 9 February 2024
- Identifiers
- RxCUI 1995288, 1995293DailyMed set ID 0f897764-fe30-090a-e063-6294a90af106NDC 70839-359Application NDA209963
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 bottle, glass in 1 carton / 4 mL in 1 bottle, glass | 70839-359-04 | Lxo | 9 February 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 14 December 2017 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Cocaine 40 mg/mL nasal solution.
Other strengths and forms of Cocaine
Clinical summary
Cocaine is a prescription medicine indicated for the induction of local anesthesia of the mucous membranes when performing diagnostic procedures and surgeries on or through the nasal cavities in adults. MedsAcross supplies Cocaine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about CocaineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Goprelto prescribing information (Lxo) · U.S. National Library of Medicine, DailyMed
Need Goprelto 40 mg/mL nasal solution for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.